☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
marketing approval
Voluntis' Oleena Digital Application Receives FDA's Marketing Approval to Self-Manage Cancer Symptoms
August 2, 2019
Fresenius Kabi's Idacio (adalimumab- biosimilar) Receives EU's Marketing Approval in Rheumatology- Gastroenterology and Dermatolog...
April 4, 2019
Exelixis and Daiichi Sankyo's Minnebro (Esaxerenone) Receives MHLW Marketing Approval In Patients With Hypertension In Japan
January 9, 2019
Coherus Biosciences' Udenyca (Pegfilgrastim Biosimilar) Receives EU Marketing Approval for Febrile Neutropenia
September 26, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.